<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Alnylam on 生物经济</title><link>https://cn.bioecon.ru/companies/alnylam/</link><description>Recent content in Alnylam on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sat, 11 Jul 2026 11:21:28 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/companies/alnylam/index.xml" rel="self" type="application/rss+xml"/><item><title>核酸药物（寡核苷酸）</title><link>https://cn.bioecon.ru/technology/nucleic-acid-therapeutics/</link><pubDate>Sat, 11 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/nucleic-acid-therapeutics/</guid><description>短链合成寡核苷酸——siRNA 与反义寡核苷酸——与靶标信使 RNA 结合，沉默或重编程致病基因，依托 GalNAc 肝靶向与糖骨架化学，在罕见病、神经系统及心血管代谢疾病领域已有多款获批药物。</description></item></channel></rss>